FDA revokes approval of Avastin for breast cancer
by Associated Press Published: November 18,2011
Tags: breast cancer, Food and drug administration, Health Care
The Food and Drug Administration has declared the blockbuster drug Avastin should no longer be used in breast cancer patients because there’s no proof it extends their lives — and it is causing dangerous side effects. Friday’s ruling was long expected, but is sure to disappoint women who say they’ve run out of other options. [...] [...]








